Soc. Generale Call 50 OMV 20.06.2.../ DE000SY1ECN8 /
8/6/2024 9:55:19 AM | Chg.+0.004 | Bid10:28:58 AM | Ask10:28:58 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.069EUR | +6.15% | 0.065 Bid Size: 45,000 |
0.075 Ask Size: 45,000 |
OMV AG | 50.00 EUR | 6/20/2025 | Call |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center